India is offering a unique COVID-19 management course in Bangla for Bangladesh.
The High Commission said this is part of India’s ‘Neighborhood First’ policy and the collaborative approach taken by Prime Minister Narendra Modi to combat the disease collectively in the region through SAARC initiative.
The e-ITEC course on Covid19 Management has been designed by All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India especially for participants from Bangladesh, it said.
The course is scheduled to be held from May 12 to May 13 and will be conducted in Bangla by medical professionals from AIIMS, Bhubaneswar.
This is the first course to be conducted in Bangla and is open for health professionals, health workers and administrators from Bangladesh.
Registrations are invited for the online course and all interested candidates may apply by visiting https://itecgoi.in/e-itec.php.
Health experts of India and Bangladesh have already held video conferences to discuss specific measures and exchange best practices on Covid19 Management.
Further, multiple online capacity building courses on Covid19 for health professionals have been designed and conducted by leading medical professionals from India under the Indian Technical & Economic Cooperation (ITEC) framework.
The first such course was conducted by AIIMS, Raipur from April 17 to April 21 and the second course being conducted by Post Graduate Institute of Medical Research (PGIMER), Chandigarh is presently underway (April 27 to May 6).
Over 150 Health professionals from Bangladesh have already benefited from these courses.
Details of all the upcoming courses are available at: https://itecgoi.in/e-itec.php.
“As a friend and neighbour, India is ready to stand with Bangladesh in times of challenge,” the High Commission said.
Narendra Modi and Prime Minister Sheikh Hasina in their telephone conversation on Wednesday reiterated the countries commitment to work together.
“Together, India and Bangladesh can overcome the extraordinary situation created by the spread of Covid-19”.